Skip to main content
. Author manuscript; available in PMC: 2020 May 31.
Published in final edited form as: Vaccine. 2019 May 8;37(25):3251–3254. doi: 10.1016/j.vaccine.2019.05.005

Table 1.

Distribution of Measles time-to-diagnosis since in days (and years) stratified by measles vaccination history, children aged 8 months – 19 years, surveillance and case-control datasets

Measles Diagnosis Time Since Vaccine Minimum Median Mean Maximum
Case-Control Dataset (2011–2015)
Missing/No Dose Information (n = 21) 247 (0.68) 518 (1.42) 1136 (3.11) 6381 (17.48)
1 Dose Received (n = 13) 248 (0.68) 301 (0.82) 1270 (3.48) 5657 (15.50)
Diagnosis time since vaccination (n = 12)* 4 (0.01) 41 (0.08) 649 (1.78) 4222 (11.57)
At least 2 doses received (n = 12) 560 (1.53) 2735 (7.49) 2434 (6.67) 4935 (13.52)
Diagnosis time since vaccination (n = 12)* 372 (1.02) 2349 (6.44) 2134 (5.86) 4593 (12.58)
Surveillance Dataset (2009–2013)
Missing/No Dose Information (n = 76) 272 (0.75) 5655 (15.49) 4011 (10.99) 6909 (18.93)
Non-Vaccinated (n = 321) 242 (0.66) 298 (0.82) 601 (1.65) 6919 (18.96)
1 Dose Received (n = 114) 242 (0.66) 364 (1.00) 664 (1.82) 6291 (17.24)
Diagnosis time since vaccination (n = 99)* 0 (0) 24 (0.07) 186 (0.51) 3253 (8.91)
At least 2 doses received (n = 48) 485 (1.33) 1557 (4.26) 2439 (6.68) 6871 (18.82)
Diagnosis time since vaccination (n = 33)* 301 (0.82) 1192 (3.27) 1778 (4.87) 5806 (15.91)
*

Additionally, for those who received any doses of the measles vaccine, we report the distribution of time-to infection since the first dose of measles vaccine in days (i.e. at approximately 8 months). This was included to clarify the time to infection since initiating the vaccination schedule.